Abstract
Diabetes mellitus is a chronic, metabolic disease defined by increased concentrations of blood glucose which leads, over time, to progressive damage in most tissues and organs including heart, blood vessels, eyes, kidneys, skin, and nerves. The most common is type 2 diabetes, commonly in adults, which occurs as result of the combination of insulin resistance with pancreatic beta cell insufficiency, with 50% of patients requiring insulin treatment within 10 years [1]. Type 1 diabetes, more frequent in children and adolescents, is a chronic autoimmune disease in which autoreactive T lymphocytes and inflammation cause severe loss of beta cells [2]. The incidence of diabetes exhibits an alarming pandemic scenario, in large part due to the global obesity epidemic [3]. Diabetes causes premature death, severe disability and great economic burden. Therefore, there is a globally agreed target to stop the growing incidence of diabetes and obesity by 2025 [4].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383(9922):1068–83.
Pugliese A. Advances in the etiology and mechanisms of type 1 diabetes. Discov Med. 2014;18(98):141–50.
World Health Organization. Global report on diabetes, Geneva. 2016. Accessed 28 Aug 2017.
United Nations. Resolution 66/2. Political declaration of the high-level meeting of the general assembly on the prevention and control of noncommunicable diseases. In:Sixty-sixth session of the United Nations General Assembly. New York: United Nations; 2011.
World Health Organization. Global status report on noncommunicable diseases 2015. Geneva: World Health Organization; 2015.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.
Addo J, Agyemang C, de-Graft Aikins A, Beune E, Schulze MB, et al. Association between socioeconomic position and the prevalence of type 2 diabetes in Ghanaians in different geographic locations: the RODAM study. J Epidemiol Community Health. 2017;71(7):633–9.
WHO mortality database [online database]. Geneva: World Health Organization. http://apps.who.int/healthinfo/statistics/mortality/causeofdeath_query/. Accessed 28 Aug 2017.
Pulgaron ER, Delamater AM. Obesity and type 2 diabetes in children: epidemiology and treatment. Curr Diab Rep. 2014;14(8):508.
Gakidou E, Mallinger L, Abbott-Klafter J, Guerrero R, Villalpando S, et al. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ. 2011;89(3):172–83.
Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract. 2013;103(2):150–60.
World Health Organization. Diabetes: equity and social determinants. In: Blas E, Kuru A, editors. Equity, social determinants and public health programmes. Geneva: World Health Organization; 2010.
DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med. 2006;23(8):857–66.
Dabelea D. The accelerating epidemic of childhood diabetes. Lancet. 2009;373(9680):1990–2000.
Bendas A, Rothe U, Kiess W, Kapellen TM, Stange T, et al. Trends in incidence rates during 1999-2008 and prevalence in 2008 of childhood type 1 diabetes mellitus in Germany. Model-based national estimates. PLoS One. 2015;10(7):e0132716.
Gupta R, Misra A. Epidemiology of microvascular complications of diabetes in South Asians and comparison with other ethnicities. J Diabetes. 2016;8(4):470–82.
United States Renal Data System. International Comparisons. In United States Renal Data System. 2014 USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2014. p. 188–210.
Moxey PW, Gogalniceanu P, Hinchliffe RJ, Loftus IM, Jones KJ, et al. Lower extremity amputations: a review of global variability in incidence. Diabet Med. 2011;28(10):1144–53.
Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73–81.
Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–77.
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–64.
Volmer-Thole M, Lobmann R. Neuropthy and diabetic foot syndrome. Int J Mol Sci. 2016;17(6):E917.
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.
Danaei G, Lawes CM, Vander HS, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet. 2006;368(9548):1651–9.
Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One. 2013;8(7):e65174.
Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes. Mechanisms, management, and clinical considerations. Circulation. 2016;133(24):2459–502.
Barengo NC, Katoh S, Moltchanov V, Tajima N, Tuomilehto J. The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study. Eur Heart J. 2008;29(15):1889–95.
Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. PharmacoEconomics. 2015;33(8):811–31.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–30.
International Diabetes Federation. IDF diabetes atlas. 6th ed. Brussels: International Diabetes Federation; 2013.
Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, et al. The global economic burden of noncommunicable diseases (working paper series). Geneva: Harvard School of Public Health and World Economic Forum; 2011.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Taverna, M.J. (2018). Epidemiology of Diabetes. In: Cohen Sabban, E., Puchulu, F., Cusi, K. (eds) Dermatology and Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-319-72475-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-72475-1_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72474-4
Online ISBN: 978-3-319-72475-1
eBook Packages: MedicineMedicine (R0)